Status:
COMPLETED
Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC
Lead Sponsor:
Seoul National University Hospital
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
This study was conducted to provide preliminary data for the main trial to compare efficacy between bipolar radiofrequency ablation (RFA) using twin internally cooled-wet electrodes and switching mono...
Eligibility Criteria
Inclusion
- radiologic or pathologic diagnosis of HCC recurrence after locoregional treatment
- HCC nodules measuring 1 cm or larger and smaller than 5 cm
Exclusion
- more than three HCC nodules
- tumors with major vascular invasion or abutment to the central portal or hepatic vein with a diameter \> 5mm
- extrahepatic metastasis
- Child-Pugh class C
- severe coagulopathy (platelet cell count of less than 50,000 cells/mm3 or prothrombin time international normalized ratio (PT-INR) prolongation of more than 50 %)
Key Trial Info
Start Date :
May 16 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2019
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT03806218
Start Date
May 16 2015
End Date
February 12 2019
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea